These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7862675)

  • 1. The minor form alpha' chain from lamprey fibrinogen is rapidly crosslinked during clotting.
    Shipwash E; Pan Y; Doolittle RF
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):968-72. PubMed ID: 7862675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fibrinogen heterogeneity: the COOH-terminal residues of defective A alpha chains of fibrinogen II.
    Nakashima A; Sasaki S; Miyazaki K; Miyata T; Iwanaga S
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):361-70. PubMed ID: 1420813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin binding to the A alpha-, B beta-, and gamma-chains of fibrinogen and to their remnants contained in fragment E.
    Kaczmarek E; McDonagh J
    J Biol Chem; 1988 Sep; 263(27):13896-900. PubMed ID: 3417681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of enzymatic hydrolysates of collagen and collagen-related synthetic peptides on fibrinogen/thrombin clotting.
    Maruyama S; Nonaka I; Tanaka H
    Biochim Biophys Acta; 1993 Jul; 1164(2):215-8. PubMed ID: 8329452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of fragment double-D from cross-linked lamprey fibrin reveals isopeptide linkages across an unexpected D-D interface.
    Yang Z; Pandi L; Doolittle RF
    Biochemistry; 2002 Dec; 41(52):15610-7. PubMed ID: 12501189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids and peptides. XVII. Synthesis of peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.
    Kawasaki K; Tsuji T; Hirase K; Miyano M; Inouye S; Iwamoto M
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):525-8. PubMed ID: 8477503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant function of a 24-Kd fragment isolated from human fibrinogen A alpha chains.
    Lau HK
    Blood; 1993 Jun; 81(12):3277-84. PubMed ID: 8507865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.
    Murthy SN; Wilson JH; Lukas TJ; Veklich Y; Weisel JW; Lorand L
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):44-8. PubMed ID: 10618368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').
    Wolfenstein-Todel C; Mosesson MW
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5069-73. PubMed ID: 6933547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA sequence of a second fibrinogen alpha chain in lamprey: an archetypal version alignable with full-length beta and gamma chains.
    Pan Y; Doolittle RF
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2066-70. PubMed ID: 1549566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins.
    Doolittle RF
    Adv Exp Med Biol; 1990; 281():25-37. PubMed ID: 2102616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
    Applegate D; Steben LS; Hertzberg KM; Grieninger G
    Blood; 2000 Apr; 95(7):2297-303. PubMed ID: 10733499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular properties of lamprey fibrinogen.
    Gladner JA; Lewis MS; Chung SI
    J Biol Chem; 1981 Feb; 256(4):1772-81. PubMed ID: 7462223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.